Home Channels Cancer Discussing Cancer Immunology & the Foreign Scholars Visa Ban with Dr....

[Podcast] Discussing Cancer Immunology & the Foreign Scholars Visa Ban with Dr. Merad

-

In their latest podcast, The Scientist LabTalk highlights Dr. Miriam Merad, a speaker at the upcoming “Myeloid Cells & Innate Immunity in Solid Tumors” eSymposia. Dr. Merad is a leader in immune-oncology research, as well as science policy, recently taking a strong stance against the Foreign Scholars Visa Ban proposed by the Trump Administration.

“Foreign post-docs are major assets to US labs, and form the major research core of most laboratories. It is because of our ability to attract these bright and motivated scientists from all over the world that the US has been able to reach such a prominent place in science,” says Merad.

She explains that impeding their entry could do irreparable harm to the dynamic, vibrant, and competitive academic workforce that ultimately drives US prowess in cutting-edge research and medical innovation.

“It took a lot of investment and vision to get where we are, and at the center of this vision is the decision to welcome scientists from all over the world and empower them to contribute to the US scientific force.”

 

Dr. Miriam Merad

Hear about Dr. Merad’s research and advocacy work on

The Scientist Lab Talk Podcast!

Lab Talk: The scientist podcast series

www.the-scientist.com/LabTalk-episode-1

 

You can hear more from Dr. Merad about her research on how dendritic cells dampen T-Cell responses against tumor cells at the upcoming virtual meeting:

Myeloid Cells and Innate Immunity in Solid Tumors” eSymposia!

myeloid cells and innate immunity in solid tumors web banner

 

Follow Dr. Merad on Twitter: @miriammerad 

Recent Publications: 

Maier, B., et al. A conserved dendritic-cell regulatory program limits antitumour immunity. Nature 580, 257–262 (2020). https://doi.org/10.1038/s41586-020-2134-y

Leader et al. CITEseq analysis of non-small-cell lung cancer lesions reveals an axis of immune cell activation associated with tumor antigen load and TP53 mutations. BioRxiv 2020. https://www.biorxiv.org/content/10.1101/2020.07.16.207605v1

Lavin Y, et al. Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses. Cell. 2017;169(4):750-765.e17. doi:10.1016/j.cell.2017.04.014

Salmon H, et al. Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. Immunity. 2016;44(4):924-938. doi:10.1016/j.immuni.2016.03.012

 


See the full upcoming eSymposia virtual meeting line-up here

    • find out about financial aid opportunities to attend for free
    • submit your abstract to present your work to global audiences
    • apply for the opportunity to be chosen to give a short talk alongside field leaders
    • …and more!

Find out more about eSymposia virtual meetings:

The Science Must Go On: Announcing eSymposia Virtual Meetings

 

 

 

 

 

Shannon Weiman
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
 

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 47-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.